Federal 340B Program Payment Scheme for Drugs Designated As Orphan Products: Congressional Clarification Needed to Close the Government-Industry Revolving Door

Detalles Bibliográficos
Autores principales: Yang, Y. Tony, Chen, Brian, Bennett, Charles L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Clinical Oncology 2016
Materias:
Comments and Controversies
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6366246/
https://www.ncbi.nlm.nih.gov/pubmed/27998222
http://dx.doi.org/10.1200/JCO.2016.68.2989

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6366246/
https://www.ncbi.nlm.nih.gov/pubmed/27998222
http://dx.doi.org/10.1200/JCO.2016.68.2989

Ejemplares similares